2 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
βGeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
45PubMed Papers
20Diseases
0Drugs
0Pathogenic Variants
DATA QUALITYβ Experimental GO Evidenceβ Swiss-Prot Reviewed
protein bindingmRNA splicing, via spliceosomepost-mRNA release spliceosomal complexnucleoplasmnephrotic syndromeeye diseasesmoking initiationmetabolic disease
Based on limited published evidence, CWF19L2 is a nucleoplasmic protein involved in mRNA splicing and post-mRNA release spliceosomal processes. CWF19L2 functions as a critical component of the intron lariat spliceosome, where it interacts with splicing machinery including DBR1, NVL2, and the RNA exosome complex 1. The protein is required for debranching of intron-derived lariat RNAs, facilitating their nuclear clearance 1. Genomic studies suggest CWF19L2 involvement in cell cycle regulation 2. The protein shares C-terminal homology with yeast Cwf19 and mammalian CWF19L1 1.
1
CWF19L2 interacts with NVL2, DBR1, and RNA exosome components; is required for debranching of intron lariat RNAs; loads into late-stage spliceosome
PMID: 414226782
CWF19L2 encodes a protein involved in cell cycle regulation based on genomic association analysis
PMID: 18398821β Limited data available β This gene has 2 indexed publications. Summary and analysis may be incomplete.
nephrotic syndromeOpen Targets
smoking initiationOpen Targets
metabolic diseaseOpen Targets
essential hypertensionOpen Targets
chronic obstructive pulmonary diseaseOpen Targets
coronary atherosclerosisOpen Targets
Increased blood pressureOpen Targets
cardiovascular diseaseOpen Targets
coronary artery diseaseOpen Targets
response to xenobiotic stimulusOpen Targets
liver diseaseOpen Targets
ankylosing spondylitisOpen Targets
cervical carcinomaOpen Targets
ovarian neoplasmOpen Targets
male infertilityOpen Targets
breast cancerOpen Targets
No pathogenic variants reported on ClinVar for this gene.